Mizuho Trust & Banking’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,656,753
Closed -$143M 106
2016
Q3
$143M Sell
2,656,753
-38,167
-1% -$2.45M 0.42% 49
2016
Q2
$198M Buy
2,694,920
+23,167
+0.9% +$1.64M 0.61% 37
2016
Q1
$171M Buy
2,671,753
+90,457
+4% +$5.7M 0.54% 42
2015
Q4
$179M Buy
2,581,296
+45,714
+2% +$3.02M 0.59% 38
2015
Q3
$150M Buy
2,535,582
+91,532
+4% +$5.81M 0.52% 42
2015
Q2
$163M Buy
2,444,050
+70,457
+3% +$4.64M 0.54% 42
2015
Q1
$153M Buy
2,373,593
+100,914
+4% +$6.32M 0.52% 42
2014
Q4
$134M Buy
2,272,679
+112,003
+5% +$6.32M 0.47% 45
2014
Q3
$111M Sell
2,160,676
-129,520
-6% -$6.47M 0.42% 50
2014
Q2
$111M Sell
2,290,196
-24,933
-1% -$1.23M 0.4% 53
2014
Q1
$120M Sell
2,315,129
-44,171
-2% -$2.35M 0.45% 45
2013
Q4
$127M Sell
2,359,300
-20,552
-0.9% -$1.05M 0.48% 44
2013
Q3
$106M Hold
2,379,852
0.44% 44
2013
Q2
$106M Buy
+2,379,852
New +$103M 0.45% 42

Other funds holding BMY

Mizuho Trust & Banking's BMY Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 2,656,753 shares — an estimated $143M sold.

Mizuho Trust & Banking first reported a position in BMY in Q2 2013 and held it in 14 quarters. The position peaked at $198M in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 2,656,753 Bristol-Myers Squibb shares in Q4 2016, an estimated $143M.
  • Mizuho Trust & Banking first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's Bristol-Myers Squibb position peaked at $198M in Q2 2016.
  • 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.